Key Highlights
- Following a CFO meeting, Bernstein’s analysis pointed to significant quantum computing advances, including 99.99% gate fidelity reached in October 2025
- The company projects delivery of a fault-tolerant system featuring 800+ logical qubits in the next three years
- IonQ transitioned to electronic qubit control systems, leveraging CMOS technology and strategic acquisitions of Oxford Ionics and Skywater for manufacturing scale
- Q1 revenue jumped 754.7% annually to $64.67 million, while EPS of -$0.34 fell short of the -$0.26 consensus
- Institutional stakeholders control 41.42% of shares, with multiple funds establishing fresh positions; shares began Thursday’s session at $54.90
IonQ (IONQ) started Thursday trading at $54.90, extending its recent upward trajectory after Bernstein SocGen’s analyst spotlighted quantum computing advancements during discussions with company leadership.
Bernstein’s Mark C. Newman noted that IonQ successfully demonstrated gate fidelity reaching at least 99.99% during October 2025 through its trapped-ion technology on a dual-qubit system. This represents a significant technical achievement in an industry where error correction has historically posed the greatest challenge to practical application.
Executives aim to deliver a fault-tolerant quantum computer exceeding 800 logical qubits, a threshold they consider essential for commercial viability. The firm anticipates hitting this target within a three-year timeframe.
The organization has simultaneously been restructuring its hardware infrastructure. It pivoted from optical qubit manipulation to electronic control mechanisms, which offer lower maintenance costs and superior mass production potential. The platform now incorporates CMOS layers combined with multiplexing techniques to expand qubit capacity.
These technical capabilities emerged through strategic acquisitions rather than purely organic development. Two key purchases—Oxford Ionics and Skywater—provided the necessary technology foundation.
Skywater Foundry Accelerates Manufacturing Timeline
Skywater’s fabrication facility now manages IonQ’s quantum chip manufacturing operations, taking over from Infineon. The production cycle has shortened considerably: Skywater delivers in 2-3 months compared to Infineon’s 9-10 month timeline. IonQ finalized the Skywater transaction in January 2026 and anticipates ongoing operational improvements throughout the integration phase.
IonQ promotes itself as the sole company offering a fully integrated quantum technology stack spanning computing, networking, cybersecurity, and sensing applications. During 2025, its research and development expenditure exceeded 2.3 times its annual revenue.
Financial Performance: Strong Sales Growth Offset by Deepening Losses
Regarding financial metrics, IonQ posted Q1 2025 revenue of $64.67 million, surpassing Wall Street projections of $49.75 million. The figure represents a 754.7% increase compared to the prior year period.
Nevertheless, earnings per share registered at -$0.34, undershooting the analyst consensus of -$0.26. The organization carries a negative return on equity of 23.20%. Full-year EPS estimates currently sit at -$2.26.
Institutional capital continues flowing into the stock. Ballast Financial Advisors initiated a position valued at approximately $449,000 during Q4. Clear Street Group established a stake worth roughly $61.5 million in Q3. Jefferies, Swedbank, Forsta AP Fonden, and ProShare Advisors similarly increased their holdings.
Institutional investors collectively own 41.42% of outstanding shares.
Wall Street analyst opinions remain divided. Rosenblatt sustained its Buy recommendation with a $100 price objective as of June 11. JPMorgan elevated its target to $50 while maintaining a Neutral stance.
Morgan Stanley established a $48.50 price target. DA Davidson reduced its objective to $35. Among 17 analysts tracking the stock, 10 assign Buy ratings, six recommend Hold, and one rates it Sell. The consensus price target stands at $68.63.
IONQ’s 52-week trading range extends from $25.89 to $84.64. The stock’s 50-day moving average sits at $51.90, while the 200-day average is $44.84.


